[HTML][HTML] Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9

TK Means, E Latz, F Hayashi, MR Murali… - The Journal of clinical …, 2005 - jci.org
TK Means, E Latz, F Hayashi, MR Murali, DT Golenbock, AD Luster
The Journal of clinical investigation, 2005jci.org
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by
pathogenic autoantibodies against nucleoproteins and DNA. Here we show that DNA-
containing immune complexes (ICs) within lupus serum (SLE-ICs), but not protein-
containing ICs from other autoimmune rheumatic diseases, stimulates plasmacytoid DCs
(PDCs) to produce cytokines and chemokines via a cooperative interaction between Toll-like
receptor 9 (TLR9) and FcγRIIa (CD32). SLE-ICs transiently colocalized to a subcellular …
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by pathogenic autoantibodies against nucleoproteins and DNA. Here we show that DNA-containing immune complexes (ICs) within lupus serum (SLE-ICs), but not protein-containing ICs from other autoimmune rheumatic diseases, stimulates plasmacytoid DCs (PDCs) to produce cytokines and chemokines via a cooperative interaction between Toll-like receptor 9 (TLR9) and FcγRIIa (CD32). SLE-ICs transiently colocalized to a subcellular compartment containing CD32 and TLR9, and CD32+, but not CD32–, PDCs internalized and responded to SLE-ICs. Our findings demonstrate a novel functional interaction between Fc receptors and TLRs, defining a pathway in which CD32 delivers SLE-ICs to intracellular lysosomes containing TLR9, inducing a signaling cascade leading to PDC activation. These data demonstrate that endogenous DNA-containing autoantibody complexes found in the serum of patients with SLE activate the innate immune system and suggest a novel mechanism whereby these ICs contribute to the pathogenesis of this autoimmune disease.
The Journal of Clinical Investigation